As of 2025-09-16, the Relative Valuation of BridgeBio Pharma Inc (BBIO) is (59.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 51.47 USD, the upside of BridgeBio Pharma Inc based on Relative Valuation is -216.0%.
The range of the Relative Valuation is (45.16) - (66.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 17.9x | 15.5x |
| Forward P/E multiples | 11.1x - 16.4x | 13.9x |
| Fair Price | (45.16) - (66.69) | (59.70) |
| Upside | -187.7% - -229.6% | -216.0% |
| Date | P/E |
| 2025-09-15 | -12.67 |
| 2025-09-12 | -12.61 |
| 2025-09-11 | -12.95 |
| 2025-09-10 | -13.04 |
| 2025-09-09 | -13.17 |
| 2025-09-08 | -13.37 |
| 2025-09-05 | -13.14 |
| 2025-09-04 | -12.76 |
| 2025-09-03 | -12.76 |
| 2025-09-02 | -12.31 |
| 2025-08-29 | -12.74 |
| 2025-08-28 | -12.94 |
| 2025-08-27 | -12.21 |
| 2025-08-26 | -12.03 |
| 2025-08-25 | -11.64 |
| 2025-08-22 | -12.08 |
| 2025-08-21 | -12.37 |
| 2025-08-20 | -12.04 |
| 2025-08-19 | -12.04 |
| 2025-08-18 | -12.07 |
| 2025-08-15 | -12.64 |
| 2025-08-14 | -12.60 |
| 2025-08-13 | -12.40 |
| 2025-08-12 | -12.09 |
| 2025-08-11 | -11.88 |
| 2025-08-08 | -11.47 |
| 2025-08-07 | -11.31 |
| 2025-08-06 | -11.03 |
| 2025-08-05 | -12.12 |
| 2025-08-04 | -11.76 |
| 2025-08-01 | -11.66 |
| 2025-07-31 | -11.64 |
| 2025-07-30 | -11.23 |
| 2025-07-29 | -11.40 |
| 2025-07-28 | -11.38 |
| 2025-07-25 | -11.40 |
| 2025-07-24 | -11.24 |
| 2025-07-23 | -11.37 |
| 2025-07-22 | -11.27 |
| 2025-07-21 | -11.30 |
| 2025-07-18 | -11.45 |
| 2025-07-17 | -11.51 |
| 2025-07-16 | -11.60 |
| 2025-07-15 | -11.56 |
| 2025-07-14 | -11.74 |
| 2025-07-11 | -11.44 |
| 2025-07-10 | -11.39 |
| 2025-07-09 | -11.32 |
| 2025-07-08 | -10.63 |
| 2025-07-07 | -10.71 |